Hyperhomocysteinemia and dyslipidemia in point mutation G307S of cystathionine β-synthase-deficient rabbit generated using CRISPR/Cas9

被引:6
|
作者
Zhang, Ting [1 ,2 ]
Lu, Rui [3 ]
Chen, Yibing [1 ,2 ]
Yuan, Yuguo [1 ,2 ]
Song, Shaozheng [4 ]
Yan, Kunning [5 ]
Zha, Yiwen [5 ]
Zhuang, Wenwen [5 ]
Cheng, Yong [1 ,2 ]
Liang, Jingyan [5 ]
机构
[1] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China
[2] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China
[3] Jiangsu Food & Pharmaceut Sci Coll, Sch Pharm, Huaian 223003, Jiangsu, Peoples R China
[4] Taihu Univ Wuxi, Sch Nursing, Wuxi 214000, Jiangsu, Peoples R China
[5] Yangzhou Univ, Med Coll, Inst Translat Med, Yangzhou 225001, Jiangsu, Peoples R China
关键词
Cystathionine beta-synthase; Hyperhomocysteinemia; Dyslipidemia; Rabbits; CRISPR/Cas9; G307S mutation; PLASMA HOMOCYSTEINE CONCENTRATIONS; FOLIC-ACID SUPPLEMENTATION; BIOMEDICAL-RESEARCH; TRANSGENIC RABBIT; MOLECULAR-BASIS; RISK-FACTOR; HOMOCYSTINURIA; CHOLESTEROL; EXPRESSION; PHENOTYPE;
D O I
10.1186/s12944-020-01394-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Congenital hyper-homocysteinemia (HHcy) is caused by a defective cystathionine beta-synthase (CBS) gene, and is frequently associated with dyslipdemia. The aim of this study was to further elucidate the effect of mutatedCBSgene on circulating lipids using a rabbit model harboring a homozygous G307S point mutation inCBS. Methods: CRISPR/Cas9 system was used to edit theCBSgene in rabbit embryos. The founder rabbits were sequenced, and their plasma homocysteine (Hcy) and lipid profile were analyzed. Results: Six CBS-knockout (CBS-KO) founder lines with biallelic modifications were obtained. Mutation in CBS caused significant growth retardation and high mortality rates within 6 weeks after birth. In addition, the 6-week oldCBS-KO rabbits showed higher plasma levels of Hcy, triglycerides (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) compared to the age-matched wild-type (WT) controls. Histological analysis of the mutants showed accumulation of micro-vesicular cytoplasmic lipid droplets in the hepatocytes. However, gastric infusion of vitamin B and betaine complex significantly decreased the plasma levels of TG, TC and LDL-C in theCBS-KO rabbits, and alleviated hepatic steatosis compared to the untreated animals. Conclusion: A CBSG307S rabbit model was generated that exhibited severe dyslipidemia when fed on a normal diet, indicating that G307S mutation in theCBSgene is a causative factor for dyslipidemia.
引用
收藏
页数:11
相关论文
共 19 条
  • [1] Hyperhomocysteinemia and dyslipidemia in point mutation G307S of cystathionine β-synthase-deficient rabbit generated using CRISPR/Cas9
    Ting Zhang
    Rui Lu
    Yibing Chen
    Yuguo Yuan
    Shaozheng Song
    Kunning Yan
    Yiwen Zha
    Wenwen Zhuang
    Yong Cheng
    Jingyan Liang
    Lipids in Health and Disease, 19
  • [2] Cystathionine β-synthase mutation G307S (G919A) is not responsible for homocysteinemia that is resistant to folate therapy in Canadian thrombosis patients.
    Donnelly, JG
    Isotalo, PA
    CLINICAL CHEMISTRY, 1999, 45 (06) : A39 - A39
  • [3] Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides
    Pawel Bialk
    Brett Sansbury
    Natalia Rivera-Torres
    Kevin Bloh
    Dula Man
    Eric B. Kmiec
    Scientific Reports, 6
  • [4] Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides
    Bialk, Pawel
    Sansbury, Brett
    Rivera-Torres, Natalia
    Bloh, Kevin
    Man, Dula
    Kmiec, Eric B.
    SCIENTIFIC REPORTS, 2016, 6
  • [5] A hypomorphic mutation in the mouse Csn1s1 gene generated by CRISPR/Cas9 pronuclear microinjection
    Smirnov, A., V
    Shnaider, T. A.
    Korablev, A. N.
    Yunusova, A. M.
    Serova, I. A.
    Battulin, N. R.
    VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2021, 25 (03): : 331 - 336
  • [6] An improved method for introducing site-directed point mutation into the Toxoplasma gondii genome using CRISPR/Cas9
    Sugi, Tatsuki
    Kato, Kentaro
    Weiss, Louis M.
    PARASITOLOGY INTERNATIONAL, 2016, 65 (05) : 558 - 562
  • [7] A novel cell line generated using the CRISPR/Cas9 technology as universal quality control material for KRAS G12V mutation testing
    Jia, Shiyu
    Zhang, Rui
    Lin, Guigao
    Peng, Rongxue
    Gao, Peng
    Han, Yanxi
    Fu, Yu
    Ding, Jiansheng
    Wu, Qisheng
    Zhang, Kuo
    Xie, Jiehong
    Li, Jinming
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (05)
  • [8] Allele-specific silencing of the gain-of-function mutation in Huntington's disease using CRISPR/Cas9
    Shin, Jun Wan
    Hong, Eun Pyo
    Choi, Doo Eun
    Seong, Ihn Sik
    Park, Seri S.
    Whittaker, Madelynn N.
    Kleinstiver, Benjamin P.
    Chen, Richard Z.
    Lee, Jong-Min
    JCI INSIGHT, 2022, 7 (19)
  • [9] Comparison of the efficiency and precision of Base editor and CRISPR/Cas9 for inducing defined point mutation (S395F) in ovine embryos
    Xu, Xin
    Zhang, Xuemei
    Peng, Xinrong
    Liu, Chunjie
    Li, Wenrong
    Liu, Mingjun
    REPRODUCTION IN DOMESTIC ANIMALS, 2022, 57 (08) : 829 - 838
  • [10] Transcriptome Analyses of β-Thalassemia-28(A>G) Mutation Using Isogenic Cell Models Generated by CRISPR/Cas9 and Asymmetric Single-Stranded Oligodeoxynucleotides (assODNs)
    Li, Jing
    Zhou, Ziheng
    Sun, Hai-Xi
    Ouyang, Wenjie
    Dong, Guoyi
    Liu, Tianbin
    Ge, Lei
    Zhang, Xiuqing
    Liu, Chao
    Gu, Ying
    FRONTIERS IN GENETICS, 2020, 11